TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 91.77M | 71.66M | 48.95M | 35.46M | 32.64M |
| Total Depreciation and Amortization | 24.60M | 23.73M | 21.59M | 19.76M | 17.68M |
| Total Amortization of Deferred Charges | 800.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.94M | 41.18M | 40.15M | 38.58M | 31.85M |
| Change in Net Operating Assets | 17.88M | -21.30M | -61.30M | -45.00M | -44.73M |
| Cash from Operations | 177.99M | 115.27M | 49.38M | 48.80M | 37.44M |
| Capital Expenditure | -57.34M | -97.92M | -112.61M | -129.74M | -157.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 441.00K | 441.00K | 441.00K | 441.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -57.34M | -97.48M | -112.17M | -129.30M | -157.52M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 15.08M | 19.17M | 22.72M | 22.87M | 22.61M |
| Repurchase of Common Stock | -138.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 14.94M | 19.17M | 22.72M | 22.87M | 22.61M |
| Foreign Exchange rate Adjustments | 489.00K | 866.00K | -5.00K | -536.00K | 443.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.08M | 37.82M | -40.07M | -58.16M | -97.02M |